Once an uncommon malignancy, cutaneous melanoma is rapidly becoming a major health
concern in the United States. It is estimated that 58,300 Americans will develop melanoma in …

Laboratory tests and imaging studies are often ordered for asymptomatic patients with
malignant melanomas (MMs) in an effort to detect subclinical metastatic disease. However …

BACKGROUND: Small-bowel tumors are rare and account for 1–2% of all gastrointestinal
neoplasms. Most of these tumors are found at surgery indicated for other diagnosis or …

Malignant melanoma metastases in the gastrointestinal tract (GIT) are found in more than
60% of autopsies on patients who have died with disseminated melanoma; however, the …

Metastatic disease in malignant melanoma often involves the visceral organs and the central
nervous system; however, it might also affect the intestine in up to 50% of the patients with …

We herein report a case of ileal invagination secondary to metastasis of a cutaneous
melanoma. A 45-year-old female was admitted with intermittent abdominal pain and nausea …

Until quite recently, surgical resection of distant melanoma metastases that were isolated or
causing symptoms was the only therapeutic strategy with any realistic chance of prolonging …

Primary cutaneous melanoma is found on the head and neck in 15% of patients, on the
limbs in 22%, on the trunk in 40%, and in occult sites in 16% 1. Only 8% of patients are …

background. Malignant melanoma is the most common met-astatic tumor of the
gastrointestinal tract and can present with abdominal pain, small bowel obstruction, or occult …

Protein-losing enteropathy is an uncommon syndrome of excessive loss of protein via the
gastrointestinal mucosa. Tc-99m dextran is a tracer ideally suited for diagnosis and …